The proportion of creatine kinase (CK; EC 2.7.3.2) isoenzyme MB activity was increased in skeletal muscle biopsies obtained from five long-distance runners, both 2 h before (mean 7.7%, SD 2.4%) and 30 mm after (mean 7.2%, SD 1.2%) a marathon race, as compared with that in biopsies from five nonrunners (controls 1.0%). Further, mitochondrial CK and CK-BB isoenzymes were present in homogenates of the runners' skeletal muscle samples but not in those of the nonrunners. However, there were no substantial differences in the mean total CK activities per gram (wet wt.) of muscle tissue among premarathon samples, postmarathon samples, and nonrunners' samples (3148, 3365, and 3049 U/g, respectively). We conclude that the metabolically active gastrocnemius muscle of long-distance runners is qualitatively similar to the heart muscle in its CK isoenzyme composition. (1, 2) . The release and clearance of CK-MB from the heart after acute myocardial infarction has also been well studied (3,4). Increases in activities of serum total CK and CK-MB and the temporal relationship of total CK and CK-MB are highly sensitive and specific for acute injury to the hQart (5, 6). However the specificity of serum CK-MB for heart muscle is not absolute; as early as 1965 Rosalki (7) showed that skeletal muscle enriched in red (slow twitch) fibers contained more CK-MB than did white (fast twitch) fibers. The recent popularity of marathon running has increased interest in measuring CK-MB activities in the sera of these runners (8-10). In the runners' blood, both during training for and after a marathon race, CK-MB percentages (1 to 10% of total CK activity) are in the range indicative of acute myocardial damage. In addition, the pattern of increase and decrease of totalCK and CK-MB in serum after a marathon race (42.2km) reportedly is similar to that after an acute myocardial infarction (11). 
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We undertook the studies reported here to: (a) determine the CK isoenzyme pattern in skeletal muscle biopsies obtained from long-distance runners; (b) compare these patterns with those for nonrunning controls; and (c) determine the relationship, if any, between the percentage of CK-MB isoenzyme and the percentage of slow-twitch muscle fibers.
Materials and Methods

Subjects
Five male long-distance marathon runners (ages 21-28; mean 25.4 years), none with cardiac risk factors (hypertension, smoking, hyperlipidemia), and five male nonrunning controls volunteered for the study after being informed of the purpose, methods, and possible complications of the procedures. Written and verbal informed consent was obtained for the study, which had been reviewed and approved by the appropriate institutional Muscle biopsies, obtained by the needle biopsy technique of Bergstrom (13), were taken from the lateral portion of the gastrocnemius muscle as described previously (14), 2 h before and within 30 mm after the race for the runners and at random times from the nonrunners. Muscle fibers were identified as slow twitch (ST) or fast twitch (Fl') on the basis of myosin ATPase (EC 3.6.1.8) activity, as described by Mabuchi and Streter (15) .
Tissue Preparation
The tissue samples were stored at -70 #{176}C in tightly sealed glass tubes. At the time of isoenzyme analysis we homogenized with 40 strokes at 4 #{176}C a precisely weighed amount (3-5 mg) of tissue in a 15-mL Dounce glass homogenizer containing 3 mL of ice-cold pH 7.2 buffer (per liter: 50 mrnol of Tris HC1, 250 mmol of sucrose, 10 mmol of EDTA, and 5 mmol of 2-mercaptoethanol). Cell fragments, including mitochondria, were removed by centrifugation (Sorvall SS-34, 15 000 rpm, 20 mm). We kept the supernates on ice and analyzed them the same day for total CK activity and CK isoenzyrnes before storing them at -70 #{176}C.
Determination of Enzyme Activity
We measured total CK activities at 30#{176}C with a kinetic enzyme analyzer (CentrifiChem 400; Baker, Pleasantville, NY) using N-acetyl-cysteine activated reagent (CalbiochemBehring, La Jolla, CA) and a modification of the Rosalki procedure (16 limit of linearity for our system for total CK was 450 UIL. In addition, for purified CK-MM or CK-MB the relation between densitometer reading and amount of isoenzyme was linear to 400 UIL. After electrophoresis, we located the isoenzymes in the presence of substrate by NADPH fluorescence, the lower limit of sensitivity being 3 U/L. To rule out non-creatine kinase artifacts, we electrophoresed samples with and without substrate (creatine phosphate). Results are reported as the mean of three separate electrophoretograms of each specimen. For standards, we used purified CK-MB from human heart muscle. The within-run precision (CV) for CK-MB was 8.3% (n = 23), compared with 8.2% between runs (n = 28). To identify isoenzyme migration we used a human CK isoenzyme control(MM, MB, BB; Beckman Instruments, Brea, CA), and we quantified the isoenzymes by scanning densitometry (Beckman Model CDS 200). The increased percentages of muscle CK-MB were verified by ion-exchange chromatography (17) .
Results Figure 1 shows a typical pattern for separation of the CK isoenzymes in muscle homogenate. Table 1 (Table 1) .
Discussion
The CK in human heart is 15 to 25% CK-MB and 75 to 85% CK-MM, with trace amounts (<1%) of mitochondrial CK and CK-BB (2) . We show that the gastrocnemius in the long-distance runners resembles heart muscle in both its mmtochondrial and cytoplasmic Their findings suggest that exercise-induced muscular necrosis occurs during training (chronic stress) and after a race (acute stress), reminiscent of rhabdomyolysis. Thus repetitive or continuous damage to and regeneration of muscle fibers could cause them to contain an increased proportion of CK-MB. Third, the stress induced by training or racing might reactivate or derepress the "B"-subunit gene to initiate and increase synthesis of CK-MB or CK-BB, or both.
CK
Mitochondrial CK has been found in human heart (25), liver (25), and brain (26), but no other report decribes (Table 1 and Figure 1) , nor have substantial amounts of CK-BB been reported in skeletal muscle. These new findings, along with reports that other oxidative and mitochondrial muscle enzymes are increased in long-distance runners (27), support our hypothesis that the metabolically active gastrocnemius tends qualitativelyto resemble heart muscle in CK isoenzyme composition. Further, the lack of significant differences in total CK activities per gram of tissue in premarathon, post-marathon, and nonrunning control samples are in agreement with previous reports (22,28).
When skeletal muscle enriched in CK-MB (up to 11% in our sampling) is damaged, as may occur in marathon runners, it should follow that increased serum CK-MB activities can be ascribed, wholly or partly, to release of CK-MB from skeletal muscle. We recently reported significantly different half-lives of circulating CK-MB during the six days after a marathon race and during the six days after acute myocardial infarction-26 h and 12 h, respectively (11)-and we postulated that CK-MB was released from damaged skeletal muscle into the circulation substantially slower (days) than the corresponding release of CK-MB after acute myocardial infarction (hours), thus accounting for the difference in clearance. However, it cannot be ruled out that the stress of marathon running causes simultaneous release of CK-MB from both heart and skeletal muscle.
In summary: we report increased CK-MB, CK-BB, and mitochondrial CK activities in biopsies of gastrocnemius muscle obtained from long-distance runners, both before and after a marathon race, as compared with nonrunning controls. We suggest that the metabolically active gastrocnemius muscle in long-distance runners adapts its CK isoenzyme composition to become qualitatively similar to that of cardiac muscle. Our findings also suggest that the higher CK-MB activity found in the serum of long-distance runners is ascribable to its release from skeletal muscle.
Thus clinicians should recognize the potential for false biochemical evidence (i.e., false-positive results)for acute myocardial infarction when interpreting patterns of CK-MB isoenzyme in serum from long-distance runners.
